Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

The Janus Face of Tumor Microenvironment Targeted by Immunotherapy.

Buoncervello M, Gabriele L, Toschi E.

Int J Mol Sci. 2019 Sep 3;20(17). pii: E4320. doi: 10.3390/ijms20174320. Review.

2.

Examining the Relationship Between Pre- and Postprandial Glucose Levels and Insulin Bolus Timing Using Bluetooth-Enabled Insulin Pen Cap Technology and Continuous Glucose Monitoring.

Toschi E, Slyne C, Greenberg JM, Greaves T, Atakov-Castillo A, Carl S, Dufour AB, Munshi M.

Diabetes Technol Ther. 2019 Sep 26. doi: 10.1089/dia.2019.0186. [Epub ahead of print]

PMID:
31483167
3.

Experiences of Adults With Type 1 Diabetes Using Glucose Sensor-Based Mobile Technology for Glycemic Variability: Qualitative Study.

Ritholz MD, Henn O, Atakov Castillo A, Wolpert H, Edwards S, Fisher L, Toschi E.

JMIR Diabetes. 2019 Jul 8;4(3):e14032. doi: 10.2196/14032.

4.

Hypoglycaemia Awareness Restoration Programme for People with Type 1 Diabetes and Problematic Hypoglycaemia Persisting Despite Optimised Self-care (HARPdoc): protocol for a group randomised controlled trial of a novel intervention addressing cognitions.

Amiel SA, Choudhary P, Jacob P, Smith EL, De Zoysa N, Gonder-Frederick L, Kendall M, Heller S, Brooks A, Toschi E, Kariyawasam D, Potts L, Healy A, Rogers H, Sevdalis N, Stadler M, Qayyum M, Bakolis I, Goldsmith K.

BMJ Open. 2019 Jun 16;9(6):e030356. doi: 10.1136/bmjopen-2019-030356.

5.

Nonadherence to Insulin Therapy Detected by Bluetooth-Enabled Pen Cap Is Associated With Poor Glycemic Control.

Munshi MN, Slyne C, Greenberg JM, Greaves T, Lee A, Carl S, Atakov-Castillo A, Toschi E.

Diabetes Care. 2019 Jun;42(6):1129-1131. doi: 10.2337/dc18-1631. Epub 2019 Mar 12.

PMID:
30862650
6.

Evaluating a Glucose-Sensor-Based Tool to Help Clinicians and Adults With Type 1 Diabetes Improve Self-Management Skills.

Toschi E, Fisher L, Wolpert H, Love M, Dunn T, Hayter G.

J Diabetes Sci Technol. 2018 Nov;12(6):1143-1151. doi: 10.1177/1932296818791534. Epub 2018 Jul 31.

7.

Mini-Dose Glucagon as a Novel Approach to Prevent Exercise-Induced Hypoglycemia in Type 1 Diabetes.

Rickels MR, DuBose SN, Toschi E, Beck RW, Verdejo AS, Wolpert H, Cummins MJ, Newswanger B, Riddell MC; T1D Exchange Mini-Dose Glucagon Exercise Study Group.

Diabetes Care. 2018 Sep;41(9):1909-1916. doi: 10.2337/dc18-0051. Epub 2018 May 18.

8.

Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial.

Beck RW, Riddlesworth TD, Ruedy K, Ahmann A, Haller S, Kruger D, McGill JB, Polonsky W, Price D, Aronoff S, Aronson R, Toschi E, Kollman C, Bergenstal R; DIAMOND Study Group.

Ann Intern Med. 2017 Sep 19;167(6):365-374. doi: 10.7326/M16-2855. Epub 2017 Aug 22.

PMID:
28828487
9.

Shiga Toxin-Producing Escherichia Coii in Slaughtered Pigs and Pork Products.

Bardasi L, Taddei R, Fiocchi I, Pelliconi MF, Ramini M, Toschi E, Merialdi G.

Ital J Food Saf. 2017 May 9;6(2):6584. doi: 10.4081/ijfs.2017.6584. eCollection 2017 Apr 13.

10.

Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.

Beck RW, Riddlesworth TD, Ruedy KJ, Kollman C, Ahmann AJ, Bergenstal RM, Bhargava A, Bode BW, Haller S, Kruger DF, McGill JB, Polonsky W, Price D, Toschi E; DIAMOND Study Group.

Lancet Diabetes Endocrinol. 2017 Sep;5(9):700-708. doi: 10.1016/S2213-8587(17)30217-6. Epub 2017 Jul 12.

PMID:
28711468
11.

Antitumor Effects of Epidrug/IFNα Combination Driven by Modulated Gene Signatures in Both Colorectal Cancer and Dendritic Cells.

Fragale A, Romagnoli G, Licursi V, Buoncervello M, Del Vecchio G, Giuliani C, Parlato S, Leone C, De Angelis M, Canini I, Toschi E, Belardelli F, Negri R, Capone I, Presutti C, Gabriele L.

Cancer Immunol Res. 2017 Jul;5(7):604-616. doi: 10.1158/2326-6066.CIR-17-0080. Epub 2017 Jun 14.

12.

Inhibition of MMP-9 expression by ritonavir or saquinavir is associated with inactivation of the AKT/Fra-1 pathway in cervical intraepithelial neoplasia cells.

Bacigalupo I, Palladino C, Leone P, Toschi E, Sgadari C, Ensoli B, Barillari G.

Oncol Lett. 2017 May;13(5):2903-2908. doi: 10.3892/ol.2017.5835. Epub 2017 Mar 9.

13.

3D Microfluidic model for evaluating immunotherapy efficacy by tracking dendritic cell behaviour toward tumor cells.

Parlato S, De Ninno A, Molfetta R, Toschi E, Salerno D, Mencattini A, Romagnoli G, Fragale A, Roccazzello L, Buoncervello M, Canini I, Bentivegna E, Falchi M, Bertani FR, Gerardino A, Martinelli E, Natale C, Paolini R, Businaro L, Gabriele L.

Sci Rep. 2017 Apr 24;7(1):1093. doi: 10.1038/s41598-017-01013-x.

14.

REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes.

Aleppo G, Ruedy KJ, Riddlesworth TD, Kruger DF, Peters AL, Hirsch I, Bergenstal RM, Toschi E, Ahmann AJ, Shah VN, Rickels MR, Bode BW, Philis-Tsimikas A, Pop-Busui R, Rodriguez H, Eyth E, Bhargava A, Kollman C, Beck RW; REPLACE-BG Study Group.

Diabetes Care. 2017 Apr;40(4):538-545. doi: 10.2337/dc16-2482. Epub 2017 Feb 16.

15.

Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.

Beck RW, Riddlesworth T, Ruedy K, Ahmann A, Bergenstal R, Haller S, Kollman C, Kruger D, McGill JB, Polonsky W, Toschi E, Wolpert H, Price D; DIAMOND Study Group.

JAMA. 2017 Jan 24;317(4):371-378. doi: 10.1001/jama.2016.19975.

PMID:
28118453
16.

Utility of Continuous Glucose Monitoring in Type 1 and Type 2 Diabetes.

Toschi E, Wolpert H.

Endocrinol Metab Clin North Am. 2016 Dec;45(4):895-904. doi: 10.1016/j.ecl.2016.06.003. Epub 2016 Sep 28. Review.

PMID:
27823610
17.

Optimized Mealtime Insulin Dosing for Fat and Protein in Type 1 Diabetes: Application of a Model-Based Approach to Derive Insulin Doses for Open-Loop Diabetes Management.

Bell KJ, Toschi E, Steil GM, Wolpert HA.

Diabetes Care. 2016 Sep;39(9):1631-4. doi: 10.2337/dc15-2855. Epub 2016 Jul 7.

PMID:
27388474
18.

Importance of primary indication and liver function between stages: results of a multicenter Italian audit of ALPPS 2012-2014.

Serenari M, Zanello M, Schadde E, Toschi E, Ratti F, Gringeri E, Masetti M, Cillo U, Aldrighetti L, Jovine E; ALPPS Italian Registry Group.

HPB (Oxford). 2016 May;18(5):419-27. doi: 10.1016/j.hpb.2016.02.003. Epub 2016 Mar 13.

19.

IFN-α potentiates the direct and immune-mediated antitumor effects of epigenetic drugs on both metastatic and stem cells of colorectal cancer.

Buoncervello M, Romagnoli G, Buccarelli M, Fragale A, Toschi E, Parlato S, Lucchetti D, Macchia D, Spada M, Canini I, Sanchez M, Falchi M, Musella M, Biffoni M, Belardelli F, Capone I, Sgambato A, Vitiani LR, Gabriele L.

Oncotarget. 2016 May 3;7(18):26361-73. doi: 10.18632/oncotarget.8379.

20.

HIV-1 TAT and IMMUNE DYSREGULATION in AIDS PATHOGENESIS: a THERAPEUTIC TARGET.

Chiozzini C, Toschi E.

Curr Drug Targets. 2016;17(1):33-45. Review.

PMID:
26302810
21.

Fructose ingestion acutely stimulates circulating FGF21 levels in humans.

Dushay JR, Toschi E, Mitten EK, Fisher FM, Herman MA, Maratos-Flier E.

Mol Metab. 2014 Oct 8;4(1):51-7. doi: 10.1016/j.molmet.2014.09.008. eCollection 2015 Jan.

22.

Sociodemographic, clinical and organisational factors associated with delayed hospital discharges: a cross-sectional study.

Lenzi J, Mongardi M, Rucci P, Di Ruscio E, Vizioli M, Randazzo C, Toschi E, Carradori T, Fantini MP.

BMC Health Serv Res. 2014 Mar 15;14:128. doi: 10.1186/1472-6963-14-128.

23.

Hospital staff education on severe sepsis/septic shock and hospital mortality: an original hypothesis.

Capuzzo M, Rambaldi M, Pinelli G, Campesato M, Pigna A, Zanello M, Barbagallo M, Girardis M, Toschi E.

BMC Anesthesiol. 2012 Nov 20;12:28. doi: 10.1186/1471-2253-12-28.

24.

HIV-1 tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodies.

Monini P, Cafaro A, Srivastava IK, Moretti S, Sharma VA, Andreini C, Chiozzini C, Ferrantelli F, Cossut MR, Tripiciano A, Nappi F, Longo O, Bellino S, Picconi O, Fanales-Belasio E, Borsetti A, Toschi E, Schiavoni I, Bacigalupo I, Kan E, Sernicola L, Maggiorella MT, Montin K, Porcu M, Leone P, Leone P, Collacchi B, Palladino C, Ridolfi B, Falchi M, Macchia I, Ulmer JB, Buttò S, Sgadari C, Magnani M, Federico MP, Titti F, Banci L, Dallocchio F, Rappuoli R, Ensoli F, Barnett SW, Garaci E, Ensoli B.

PLoS One. 2012;7(11):e48781. doi: 10.1371/journal.pone.0048781. Epub 2012 Nov 13.

25.
26.

Fibroblast Growth Factor-2 and the HIV-1 Tat Protein Synergize in Promoting Bcl-2 Expression and Preventing Endothelial Cell Apoptosis: Implications for the Pathogenesis of AIDS-Associated Kaposi's Sarcoma.

Sgadari C, Barillari G, Palladino C, Bellino S, Taddeo B, Toschi E, Ensoli B.

Int J Vasc Med. 2011;2011:452729. doi: 10.1155/2011/452729. Epub 2011 Oct 9.

27.

Rat neonatal beta cells lack the specialised metabolic phenotype of mature beta cells.

Jermendy A, Toschi E, Aye T, Koh A, Aguayo-Mazzucato C, Sharma A, Weir GC, Sgroi D, Bonner-Weir S.

Diabetologia. 2011 Mar;54(3):594-604. doi: 10.1007/s00125-010-2036-x. Epub 2011 Jan 16.

28.

The activity of matrix metalloproteinase-9 is part of the mechanism of cell-to-cell HIV-1 endocytosis in dendritic cells.

Ruggiero E, Toschi E, Federico M.

Curr Drug Discov Technol. 2011 Jun;8(2):112-8.

PMID:
21190541
29.

Mafa expression enhances glucose-responsive insulin secretion in neonatal rat beta cells.

Aguayo-Mazzucato C, Koh A, El Khattabi I, Li WC, Toschi E, Jermendy A, Juhl K, Mao K, Weir GC, Sharma A, Bonner-Weir S.

Diabetologia. 2011 Mar;54(3):583-93. doi: 10.1007/s00125-010-2026-z. Epub 2010 Dec 29.

30.

Human immunodeficiency virus protease inhibitors reduce the growth of human tumors via a proteasome-independent block of angiogenesis and matrix metalloproteinases.

Toschi E, Sgadari C, Malavasi L, Bacigalupo I, Chiozzini C, Carlei D, Compagnoni D, Bellino S, Bugarini R, Falchi M, Palladino C, Leone P, Barillari G, Monini P, Ensoli B.

Int J Cancer. 2011 Jan 1;128(1):82-93. doi: 10.1002/ijc.25550.

31.

Identification of markers for newly formed beta-cells in the perinatal period: a time of recognized beta-cell immaturity.

Aye T, Toschi E, Sharma A, Sgroi D, Bonner-Weir S.

J Histochem Cytochem. 2010 Apr;58(4):369-76. doi: 10.1369/jhc.2009.954909. Epub 2010 Jan 4.

32.

Clinical course of classic Kaposi's sarcoma in HIV-negative patients treated with the HIV protease inhibitor indinavir.

Monini P, Sgadari C, Grosso MG, Bellino S, Di Biagio A, Toschi E, Bacigalupo I, Sabbatucci M, Cencioni G, Salvi E, Leone P, Ensoli B.

AIDS. 2009 Feb 20;23(4):534-8. doi: 10.1097/QAD.0b013e3283262a8d.

PMID:
19169139
33.

Transdifferentiation of pancreatic ductal cells to endocrine beta-cells.

Bonner-Weir S, Inada A, Yatoh S, Li WC, Aye T, Toschi E, Sharma A.

Biochem Soc Trans. 2008 Jun;36(Pt 3):353-6. doi: 10.1042/BST0360353.

PMID:
18481956
34.

Macrophages transmit human immunodeficiency virus type 1 products to CD4-negative cells: involvement of matrix metalloproteinase 9.

Muratori C, Sistigu A, Ruggiero E, Falchi M, Bacigalupo I, Palladino C, Toschi E, Federico M.

J Virol. 2007 Sep;81(17):9078-87. Epub 2007 Jun 20.

35.

The use of HAART for biological tumour therapy.

Monini P, Toschi E, Sgadari C, Bacigalupo I, Palladino C, Carlei D, Barillari G, Ensoli B.

J HIV Ther. 2006 Sep;11(3):53-6. Review. No abstract available.

PMID:
17580499
36.

Protein-tyrosine phosphatase 1B deficiency reduces insulin resistance and the diabetic phenotype in mice with polygenic insulin resistance.

Xue B, Kim YB, Lee A, Toschi E, Bonner-Weir S, Kahn CR, Neel BG, Kahn BB.

J Biol Chem. 2007 Aug 17;282(33):23829-40. Epub 2007 Jun 1.

37.

Control of human herpes virus type 8-associated diseases by NK cells.

Sirianni MC, Campagna M, Scaramuzzi D, Carbonari M, Toschi E, Bacigalupo I, Monini P, Ensoli B.

Ann N Y Acad Sci. 2007 Jan;1096:37-43.

PMID:
17405914
38.

Changes in gene expression in beta cells after islet isolation and transplantation using laser-capture microdissection.

Ahn YB, Xu G, Marselli L, Toschi E, Sharma A, Bonner-Weir S, Sgroi DC, Weir GC.

Diabetologia. 2007 Feb;50(2):334-42. Epub 2006 Dec 16.

PMID:
17180350
39.

Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes.

Natali A, Toschi E, Baldeweg S, Ciociaro D, Favilla S, Saccà L, Ferrannini E.

Diabetes. 2006 Apr;55(4):1133-40.

40.

How can we get more beta cells?

Inada A, Bonner-Weir S, Toschi E.

Curr Diab Rep. 2006 Apr;6(2):96-101. Review.

PMID:
16542618
41.

HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathway.

Toschi E, Bacigalupo I, Strippoli R, Chiozzini C, Cereseto A, Falchi M, Nappi F, Sgadari C, Barillari G, Mainiero F, Ensoli B.

Mol Biol Cell. 2006 Apr;17(4):1985-94. Epub 2006 Jan 25.

42.

Haematocrit, type 2 diabetes, and endothelium-dependent vasodilatation of resistance vessels.

Natali A, Toschi E, Baldeweg S, Casolaro A, Baldi S, Sironi AM, Yudkin JS, Ferrannini E.

Eur Heart J. 2005 Mar;26(5):464-71. Epub 2005 Feb 3.

PMID:
15691863
43.

The pancreatic ductal epithelium serves as a potential pool of progenitor cells.

Bonner-Weir S, Toschi E, Inada A, Reitz P, Fonseca SY, Aye T, Sharma A.

Pediatr Diabetes. 2004;5 Suppl 2:16-22. Review.

PMID:
15601370
44.

Antitumour effects of antiretroviral therapy.

Monini P, Sgadari C, Toschi E, Barillari G, Ensoli B.

Nat Rev Cancer. 2004 Nov;4(11):861-75. Review.

PMID:
15516959
45.

Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes.

Natali A, Baldeweg S, Toschi E, Capaldo B, Barbaro D, Gastaldelli A, Yudkin JS, Ferrannini E.

Diabetes Care. 2004 Jun;27(6):1349-57.

PMID:
15161787
46.

HIV protease inhibitors as new treatment options for Kaposi's sarcoma.

Barillari G, Sgadari C, Toschi E, Monini P, Ensoli B.

Drug Resist Updat. 2003 Aug;6(4):173-81.

PMID:
12962683
47.

[HIV protease inhibitors for the treatment of Kaposi's sarcoma].

Grosso G, Sgadari C, Barillari G, Toschi E, Bacigalupo I, Carlei D, Palladino C, Baccarini S, Malavasi L, Moracci G, Leone P, Chiozzini C, Monini P, Ensoli B.

Recenti Prog Med. 2003 Feb;94(2):69-74. Review. Italian.

PMID:
12908373
48.

Induction of Mad expression leads to augmentation of insulin gene transcription.

Patané G, Kaneto H, Toschi E, Sharma A, Gupta S, Weir GC.

Biochem Biophys Res Commun. 2003 Apr 18;303(4):1199-208.

PMID:
12684063
49.

Treatment of Kaposi's sarcoma--an update.

Toschi E, Sgadari C, Monini P, Barillari G, Bacigalupo I, Palladino C, Baccarini S, Carlei D, Grosso G, Sirianni MC, Ensoli B.

Anticancer Drugs. 2002 Nov;13(10):977-87. Review.

PMID:
12439331
50.

HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma.

Sgadari C, Barillari G, Toschi E, Carlei D, Bacigalupo I, Baccarini S, Palladino C, Leone P, Bugarini R, Malavasi L, Cafaro A, Falchi M, Valdembri D, Rezza G, Bussolino F, Monini P, Ensoli B.

Nat Med. 2002 Mar;8(3):225-32.

PMID:
11875492

Supplemental Content

Loading ...
Support Center